Apparently Cellceutix wants to move towards mod/severe also. That will require upping the dosage in another P2 trial. The FDA isn't going to say oh ok Leo up the dosage to 300mg for this P3 trial and lets see what it does for mod/severe...Sorry but another P2 is coming...
(0)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links